139 related articles for article (PubMed ID: 2452225)
1. [Prenatal pharmacology of low molecular weight heparin and pentosan polysulfate].
Rainaut M; Forestier F; Daffos F; Fisher AM; Aiach M
J Mal Vasc; 1987; 12 Suppl B():119-22. PubMed ID: 2452225
[TBL] [Abstract][Full Text] [Related]
2. Absence of transplacental passage of pentosan polysulfate during mid trimester of pregnancy.
Forestier F; Fischer AM; Daffos F; Beguin S; Diner H
Thromb Haemost; 1986 Dec; 56(3):247-9. PubMed ID: 2436327
[TBL] [Abstract][Full Text] [Related]
3. [Absence of transplacental passage of Fraxiparin (low molecular weight heparin) during the 3d trimester of pregnancy].
Forestier F; Daffos F; Rainaut M; Toulemonde F
J Gynecol Obstet Biol Reprod (Paris); 1987; 16(8):981-6. PubMed ID: 2836497
[TBL] [Abstract][Full Text] [Related]
4. Absence of transplacental passage of fragmin (Kabi) during the second and the third trimesters of pregnancy.
Forestier F; Solé Y; Aiach M; Alhenc Gélas M; Daffos F
Thromb Haemost; 1992 Jan; 67(1):180-1. PubMed ID: 1319615
[No Abstract] [Full Text] [Related]
5. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection.
Fischer AM; Merton RE; Marsh NA; Williams S; Gaffney PJ; Barrowcliffe TW; Thomas DP
Thromb Haemost; 1982 Apr; 47(2):109-13. PubMed ID: 6179183
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacology of a heparinoid derived from pentosan].
Lansen J; Diner H
Agressologie; 1983 Dec; 24(12):591-5. PubMed ID: 6199994
[No Abstract] [Full Text] [Related]
7. Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro.
Baba M; Nakajima M; Schols D; Pauwels R; Balzarini J; De Clercq E
Antiviral Res; 1988 Sep; 9(6):335-43. PubMed ID: 2465736
[TBL] [Abstract][Full Text] [Related]
8. Experimental and clinical pharmacology of pentosan polysulfate.
Maffrand JP; Herbert JM; Bernat A; Defreyn G; Delebassee D; Savi P; Pinot JJ; Sampol J
Semin Thromb Hemost; 1991; 17 Suppl 2():186-98. PubMed ID: 1719639
[No Abstract] [Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of warfarin when coadministered with pentosan polysulfate sodium.
Modi NB; Kell S; Simon M; Vargas R
J Clin Pharmacol; 2005 Aug; 45(8):919-26. PubMed ID: 16027402
[TBL] [Abstract][Full Text] [Related]
10. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
Fischer AM; Barrowcliffe TW; Thomas DP
Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
[TBL] [Abstract][Full Text] [Related]
11. Comparative turn-over of heparin cofactor II and antithrombin III in baboons. Influence of heparin and pentosan polysulfate administration.
Sié P; Lansen J; Lacheretz F; Verschuere B; Boneu B
Thromb Haemost; 1986 Dec; 56(3):302-7. PubMed ID: 2436331
[TBL] [Abstract][Full Text] [Related]
12. Low molecular weight heparin Novo (LHN-1) does not cross the placenta during the second trimester of pregnancy.
Omri A; Delaloye JF; Andersen H; Bachmann F
Thromb Haemost; 1989 Feb; 61(1):55-6. PubMed ID: 2546279
[TBL] [Abstract][Full Text] [Related]
13. Comparison between commercial heparin, low molecular weight heparin and pentosan polysulfate on hemostasis and platelets in vivo.
Esquivel CO; Bergqvist D; Björck CG; Nilsson B
Thromb Res; 1982 Nov; 28(3):389-99. PubMed ID: 6184845
[TBL] [Abstract][Full Text] [Related]
14. Sulfated polysaccharide anticoagulants suppress natural killer cell activity in vitro.
Johann S; Zoller C; Haas S; Blümel G; Lipp M; Förster R
Thromb Haemost; 1995 Oct; 74(4):998-1002. PubMed ID: 8560445
[TBL] [Abstract][Full Text] [Related]
15. Effect of pentosan polysulfate (SP 54) on the reverse transcriptase activity of several retroviruses.
Sydow G; Klöcking HP
Biomed Biochim Acta; 1987; 46(6):527-30. PubMed ID: 2445339
[TBL] [Abstract][Full Text] [Related]
16. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
Delsart D; Chambefort V; Decousus H
Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
[No Abstract] [Full Text] [Related]
17. In vitro anticoagulation monitoring of low-molecular-weight heparin.
Wang JQ; Shi XB; Yang JG; Hu DY
Chin Med J (Engl); 2009 May; 122(10):1199-202. PubMed ID: 19493471
[TBL] [Abstract][Full Text] [Related]
18. Selenium and malondialdehyde content and glutathione peroxidase activity in maternal and umbilical cord blood and amniotic fluid.
Mihailović M; Cvetković M; Ljubić A; Kosanović M; Nedeljković S; Jovanović I; Pesut O
Biol Trace Elem Res; 2000 Jan; 73(1):47-54. PubMed ID: 10949968
[TBL] [Abstract][Full Text] [Related]
19. The effect of a sulfated polysaccharide on antithrombin III.
Czapek EE; Kwaan HC; Szczecinski M
J Lab Clin Med; 1980 Jun; 95(6):783-90. PubMed ID: 6155418
[TBL] [Abstract][Full Text] [Related]
20. Heparin-induced thrombocytopenia and pentosan polysulfate: treatment with a low molecular weight heparin despite in vitro platelet aggregation.
Vitoux JF; Roncato M; Hourdebaigt P; Aiach M; Fiessinger JN
Thromb Haemost; 1986 Apr; 55(2):294-5. PubMed ID: 2424119
[No Abstract] [Full Text] [Related]
[Next] [New Search]
